123 related articles for article (PubMed ID: 15802397)
1. Antidepressant medication use [corrected] and risk of ovarian cancer.
Moorman PG; Berchuck A; Calingaert B; Halabi S; Schildkraut JM
Obstet Gynecol; 2005 Apr; 105(4):725-30. PubMed ID: 15802397
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoking and risk of epithelial ovarian cancer.
Rossing MA; Cushing-Haugen KL; Wicklund KG; Weiss NS
Cancer Causes Control; 2008 May; 19(4):413-20. PubMed ID: 18080774
[TBL] [Abstract][Full Text] [Related]
3. Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study.
Nishtala PS; McLachlan AJ; Bell JS; Chen TF
Am J Geriatr Pharmacother; 2009 Aug; 7(4):210-9. PubMed ID: 19766953
[TBL] [Abstract][Full Text] [Related]
4. Psychotropic medication use and risk of epithelial ovarian cancer.
Harlow BL; Cramer DW; Baron JA; Titus-Ernstoff L; Greenberg ER
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):697-702. PubMed ID: 9718222
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant medication use and non-Hodgkin's lymphoma risk: no association.
Bahl S; Cotterchio M; Kreiger N; Klar N
Am J Epidemiol; 2004 Sep; 160(6):566-75. PubMed ID: 15353417
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
[TBL] [Abstract][Full Text] [Related]
7. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
[TBL] [Abstract][Full Text] [Related]
8. Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.
Schildkraut JM; Moorman PG; Bland AE; Halabi S; Calingaert B; Whitaker R; Lee PS; Elkins-Williams T; Bentley RC; Marks JR; Berchuck A
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):585-93. PubMed ID: 18349276
[TBL] [Abstract][Full Text] [Related]
9. Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study.
Chen Y; Guo JJ; Li H; Wulsin L; Patel NC
Ann Pharmacother; 2008 Feb; 42(2):177-84. PubMed ID: 18212255
[TBL] [Abstract][Full Text] [Related]
10. Body weight and body mass index and ovarian cancer risk: a case-control study in China.
Zhang M; Xie X; Holman CD
Gynecol Oncol; 2005 Aug; 98(2):228-34. PubMed ID: 15979697
[TBL] [Abstract][Full Text] [Related]
11. Relation of anthropometric measurements to ovarian cancer risk in a population-based case-control study (United States).
Peterson NB; Trentham-Dietz A; Newcomb PA; Chen Z; Gebretsadik T; Hampton JM; Stampfer MJ; Willett WC; Egan KM
Cancer Causes Control; 2006 May; 17(4):459-67. PubMed ID: 16596298
[TBL] [Abstract][Full Text] [Related]
12. Anthropometry and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Ness RB; Allen GO
Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
[TBL] [Abstract][Full Text] [Related]
13. Menopausal hormones and risk of ovarian cancer.
Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant drug use and risk of venous thromboembolism.
Jick SS; Li L
Pharmacotherapy; 2008 Feb; 28(2):144-50. PubMed ID: 18225961
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for benign serous and mucinous epithelial ovarian tumors.
Jordan SJ; Green AC; Whiteman DC; Webb PM
Obstet Gynecol; 2007 Mar; 109(3):647-54. PubMed ID: 17329516
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant drug prescription and risk of abnormal bleeding: a case-control study.
Barbui C; Andretta M; De Vitis G; Rossi E; D'Arienzo F; Mezzalira L; De Rosa M; Cipriani A; Berti A; Nosè M; Tansella M; Bozzini L
J Clin Psychopharmacol; 2009 Feb; 29(1):33-8. PubMed ID: 19142104
[TBL] [Abstract][Full Text] [Related]
17. Analgesic drug use and risk of epithelial ovarian cancer.
Hannibal CG; Rossing MA; Wicklund KG; Cushing-Haugen KL
Am J Epidemiol; 2008 Jun; 167(12):1430-7. PubMed ID: 18390840
[TBL] [Abstract][Full Text] [Related]
18. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.
Soegaard M; Jensen A; Høgdall E; Christensen L; Høgdall C; Blaakaer J; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1160-6. PubMed ID: 17548679
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and ovarian cancer risk: a meta-analysis.
Zhou B; Sun Q; Cong R; Gu H; Tang N; Yang L; Wang B
Gynecol Oncol; 2008 Mar; 108(3):641-51. PubMed ID: 18221779
[TBL] [Abstract][Full Text] [Related]
20. Occupational exposures and the risk of ovarian cancer in Sweden.
Shields T; Gridley G; Moradi T; Adami J; Plato N; Dosemeci M
Am J Ind Med; 2002 Sep; 42(3):200-13. PubMed ID: 12210689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
